Phase II Prospective Study Evaluating the Role of Directed Cisplatin Based Chemo With Either Vinorelbine or Pemetrexed for the Adj Tx of Early Stage NSCLC in Patients Using Genomic Expression Profiles of Chemo Sensitivity to Guide Therapy.
Phase of Trial: Phase II
Latest Information Update: 23 Sep 2014
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms TOP0703
- 07 Jun 2017 Biomarkers information updated
- 03 Feb 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 23 Jul 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.